Tafenoquine for the prevention of Plasmodium vivax malaria relapse
Saved in:
Main Authors: | James A. Watson, Narimane Nekkab, Michael White |
---|---|
Other Authors: | Faculty of Tropical Medicine, Mahidol University |
Format: | Letter |
Published: |
2022
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/77295 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Randomized dose-ranging study of the safety and efficacy of WR 238605 (Tafenoquine) in the prevention of relapse of Plasmodium vivax malaria in Thailand
by: Douglas S. Walsh, et al.
Published: (2018) -
Tafenoquine versus primaquine to prevent relapse of plasmodium vivax malaria
by: Alejandro Llanos-Cuentas, et al.
Published: (2020) -
Single-dose tafenoquine to prevent relapse of plasmodium vivax malaria
by: Marcus V.G. Lacerda, et al.
Published: (2020) -
Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse
by: Douglas S. Walsh, et al.
Published: (2018) -
Management of relapsing Plasmodium vivax malaria
by: Cindy S. Chu, et al.
Published: (2018)